Erratum: A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states
Erratum to: Ann Transl Med 2022;10:1382.
The article (1) titled “A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states” (doi: 10.21037/atm-22-5520) unfortunately contains errors in Figure 5.
The images of Figure 5C selected to represent the tumorigenesis of AML xenograft mice were duplicated accidentally.
Figure 5C of the original article:
Figure 5C after correction:
Furthermore, the image in Figure 5E, intended to depict the hCD45+ immunohistochemistry staining results from the liver of the “PBMC+IL-2+Thal” group, was misused.
Figure 5E of the original article:
Figure 5E after correction:
The correct version of Figure 5, containing the correct data for the tumorigenesis of AML xenograft mice in Figure 5C and the hCD45+ immunohistochemical staining results of the livers in AML xenograft mice in Figure 5E is shown below.
These errors did not significantly affect either the results or the conclusions of the paper.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Mi R, Chen L, Wang X, et al. A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states. Ann Transl Med 2022;10:1382. [Crossref] [PubMed]
